OmniSight™ 3D Imaging Platform

OmniSight™: Transforming Complex Biological Structures into Quantifiable 3D Digital Maps through an Integrated "Dosing-to-Data" Workflow.

Platform Overview

Transitioning from 2D Histology to 3D Spatial Insights

OmniSight™ leverages advanced tissue clearing and light-sheet microscopy to provide high-resolution, three-dimensional visualization of intact biological specimens. Unlike traditional sectioning, we offer an integrated "Dosing-to-Data" workflow—combining expert animal modeling with deep-tissue imaging—to transform complex biological structures into quantifiable digital maps, ensuring no pathological detail is missed.

Platform Core

A. DeepTissue: Whole-Organ Clearing & In Vivo Integration

We bridge the gap between animal modeling and pathology. Our team manages the entire experimental phase—from disease model induction and precision dosing (IV, IT, ICV, etc.) to the specialized clearing of target organs. By rendering tissues optically transparent while preserving endogenous signals, we capture the true anatomical context of your therapeutic candidate.

B. Vantage3D: AI-Powered Spatial Quantitation & Analytics

Raw 3D images are converted into actionable datasets through our proprietary AI engine. We provide automated segmentation and skeletonization of biological networks, offering precise metrics such as vascular branching, neuronal density, and tumor-stroma spatial relationships, removing the bias of manual 2D counting.

C. TargetTrack: Precision 3D PK/PD & Delivery Mapping

Specifically designed for advanced modalities (AAV, LNP, mAbs, and Exosomes), TargetTrack visualizes the true penetration depth and cellular uptake across entire tissue volumes. We provide definitive 3D evidence of whether your drug successfully crosses biological barriers (e.g., BBB) and engages with the intended deep-tissue targets.

OmniSight™ Technical Specifications

Phase	Specification	Technical Details
In Vivo Integration	Administration Routes	IV, IT, ICV, IP, and targeted organ injection.
In Vivo Integration	Animal Models	Expertise in disease model induction and precision dosing.
Tissue Clearing	Transparency Method	Proprietary chemical reagents for optical transparency.
	Signal Preservation	Maintains endogenous fluorescence (e.g., GFP, RFP) and molecular signals.
	Tissue Types	Compatible with Brain, Heart, Liver, Kidney, and fibrotic/calcified specimens.
3D Imaging	Microscopy Type	High-speed Light-sheet (LSFM) and Confocal microscopy.
3D Imaging	Resolution	Sub-cellular to whole-organ volumetric imaging.
AI Data Analytics	Quantitation Metrics	Vascular branching, neuronal density, and tumor-stroma spatial relationships.
AI Data Analytics	Processing Engine	AI-powered automated segmentation and 3D rendering (Vantage3D).
Deliverables	Standard Formats	High-definition .mp4 videos, publication-ready snapshots, and Excel/PDF reports.
Deliverables	Advanced Outputs	Interactive 3D files and structured raw datasets for internal analysis.

Platform Advantages

Feature	Description
Structural Integrity	Preserves original tissue architecture without the artifacts or information loss of mechanical sectioning.
Complete Volumetric Data	Captures high-resolution 3D information of entire intact organs (Brain, Heart, Liver, Kidney, etc.).
High Throughput	Optimized rapid-clearing protocols and automated imaging workflows ensure fast turnaround for large-scale studies.
Universal Compatibility	Applicable to diverse and challenging tissue types, including highly fibrotic, fatty, or calcified specimens.
Live-Sync Capability	Optional intravital imaging for real-time observation of blood flow, calcium signaling, and cell-cell dynamics.
Precision Analytics	AI-driven segmentation provides automated statistical analysis of 3D spatial markers and volumetric measurements.

Platform Applications

Neuroscience: Comprehensive mapping of neural circuits, neurodegeneration, and amyloid plaque distribution in intact brains.
Oncology: 3D visualization of CAR-T/immune cell infiltration depth and tumor vascularization architecture.
Gene & Cell Therapy: Quantitative evaluation of AAV/LNP vector biodistribution and cell-specific expression efficiency.
Cardiovascular & Renal: Assessing myocardial infarction volume, angiogenesis at the capillary level, and glomerular structural changes.

Case Study

3D Mapping of Neurovascular Networks in Whole Brains

To demonstrate the transformative power of our workflow, we reference foundational methodologies (e.g., Nature Methods) that underpin the OmniSight™ platform.

The Challenge: Traditional 2D histology captures less than 1% of tissue volume, leading to significant bias in quantifying complex structures like the blood-brain barrier (BBB).

The Solution: Utilizing advanced tissue clearing (similar to the DeepTissue module) allows for intact organ transparency while preserving endogenous fluorescence.

Quantitative Impact: By applying AI-driven skeletonization (as seen in Vantage3D), researchers can achieve 100% volumetric coverage, revealing 3D spatial markers like vessel branching and plaque distribution that are invisible in 2D sections.

Conclusion: This "Dosing-to-Data" approach ensures that therapeutic candidates—such as AAVs or LNPs—are evaluated with complete anatomical context.

Scientific References for this Methodology:

Structural Integrity: Chung, K. et al. Structural and molecular interrogation of intact biological systems. Nature. 2013 May 16;497(7449):332-7.
Vascular Quantification: Todorov, M. I. et al. Machine learning analysis of whole mouse brain vasculature. Nat Methods. 2020 Apr;17(4):442-449.
Whole-organ Mapping: Pan, C., et al. Shrinkage-mediated imaging of entire organs and organisms using uDISCO. Nat Methods. 2016 Oct;13(10):859-67.

Workflow

In Vivo Modeling & Dosing: Expert animal study execution, including specialized drug administration and model development.

Tissue Clearing: Application of proprietary chemical reagents to achieve optical transparency while maintaining molecular signals.

3D Imaging: High-speed, high-resolution acquisition using light-sheet or confocal microscopy.

Data Processing: Advanced image stitching, 3D rendering, and AI-based quantitative feature extraction.

Digital Delivery: Comprehensive study reports including interactive 3D models, cinematic fly-throughs, and structured raw datasets.

FAQs

Q1: What are the primary benefits of 3D histology over traditional 2D IHC? Traditional histology only captures <1% of the tissue volume, often missing localized pathological features. 3D histology visualizes the entire intact organ, providing a statistically robust and spatially accurate dataset of drug distribution and efficacy.

Q2: Can this platform evaluate the infiltration of CAR-T cells in solid tumors? Yes. OmniSight™ is uniquely suited for oncology studies, allowing us to quantify the exact penetration depth and spatial clustering of immune cells within the complex 3D tumor microenvironment.

Q3: How do you handle the "Dosing-to-Data" workflow for gene therapy? We manage the entire process: we perform the viral vector injections in our animal facility, allow for expression, and then clear the target tissues to map the total vector biodistribution across the whole organ.

Q4: Is the quantitative data provided by Vantage3D reproducible? Absolutely. By using AI-powered automated segmentation, we eliminate the subjective bias of human observation, ensuring that measurements like vessel density or plaque volume are highly precise and reproducible across study groups.

Q5: What file formats are included in the final report? We provide high-definition 3D videos (.mp4), publication-ready snapshots, and full quantitative reports (Excel/PDF). We also offer access to interactive 3D files for your internal presentations.